Growth of Human and Sheep Corneal Endothelial Cell Layers on Biomaterial Membranes
February 6th, 2020
7.7K views
This protocol describes the critical steps required to establish and grow corneal endothelial cell cultures from explants of human or sheep tissue. A method for subculturing corneal endothelial cells on membranous biomaterials is also presented.
Overview
This protocol describes the critical steps required to establish and grow corneal endothelial cell cultures from explants of human or sheep tissue. It aims to prevent epithelial to mesenchymal transition during isolation, expansion, and subculture.
Key Study Components
Area of Science
- Cell culture techniques
- Corneal biology
- Tissue engineering
Background
- Corneal endothelial cells are essential for maintaining corneal transparency.
- Primary cell cultures can be established from corneal tissue explants.
- Subculturing on biomaterials can enhance cell growth.
- Preventing epithelial to mesenchymal transition is crucial for cell viability.
Purpose of Study
- To provide a reliable method for culturing corneal endothelial cells.
- To ensure a continuous supply of primary cells from a single donor.
- To maintain the integrity of the endothelial phenotype during culture.
Methods Used
- Coating tissue culture plates with attachment factor.
- Using culture medium for cell growth.
- Isolating corneal endothelium under a dissecting microscope.
- Adjusting illumination and zoom for optimal viewing of the endothelial layer.
Main Results
- Successful establishment of corneal endothelial cell cultures.
- Maintenance of cell phenotype during culture processes.
- Feasibility of using tissue explants for ongoing cell supply.
- Effective prevention of epithelial to mesenchymal transition.
Conclusions
- The protocol provides a robust method for corneal endothelial cell culture.
- It allows for the sustainable use of donor tissue.
- Maintaining cell phenotype is critical for future applications in regenerative medicine.
Frequently Asked Questions
What are corneal endothelial cells?
Corneal endothelial cells are specialized cells that maintain the transparency of the cornea by regulating fluid and solute transport.
Why is preventing epithelial to mesenchymal transition important?
Preventing this transition is crucial to maintain the functional characteristics of corneal endothelial cells during culture.
How can primary cells be reused from a single donor?
Primary cells can be continuously cultured from corneal tissue explants, allowing for repeated use of the same donor tissue.
What is the role of the attachment factor in cell culture?
The attachment factor promotes the adherence of corneal endothelial cells to the culture plate, enhancing cell growth and viability.
What are the implications of this research?
This research has potential applications in regenerative medicine and corneal transplantation, providing a sustainable source of endothelial cells.
Executive Industry Relevance
This protocol addresses a key challenge in ocular regenerative medicine: maintaining corneal endothelial cell phenotype during expansion to prevent epithelial-to-mesenchymal transition (EMT), which compromises barrier function. By enabling reproducible, scalable culture of primary human and sheep corneal endothelial cells from tissue explants, the method supports preclinical development of tissue-engineered corneal grafts. It provides a renewable cell source for evaluating biomaterial compatibility and endothelial layer integrity in transplantation models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of corneal endothelial phenotype stability by preserving ZO-1 and N-cadherin junctional markers during culture.
- Operational Value: Provides a renewable source of primary cells from single donor explants, reducing variability and enabling consistent target validation assays.
Screening & Assay Development
- Scientific Value: Supports development of functional assays for endothelial barrier integrity using electrical resistance measurements on biomaterial membranes.
- Operational Value: Standardizes cell seeding and subculture via dispase II-based lifting, improving reproducibility across screening campaigns.
Translational & Preclinical Research
- Scientific Value: Facilitates preclinical evaluation of tissue-engineered constructs by enabling corneal endothelial layer formation on collagen type I membranes for animal transplantation studies.
- Operational Value: Uses a custom micro Boyden chamber to support simultaneous culture on both sides of a membrane, enabling stromal-endothelial co-culture models for graft optimization.
Pipeline & Workflow Integration
The method integrates into the discovery continuum by providing phenotype-stable corneal endothelial cells for target validation, progressing to biomaterial-compatible cell layers for preclinical graft assessment.
- Discovery Biology: Supports hypothesis testing on endothelial-mesenchymal transition inhibitors through stable, contact-inhibited cell cultures.
- Screening: Enables assay-ready cultures with quantifiable outputs such as junctional protein localization and electrical resistance.
- Analytics: Generates measurable endpoints including ZO-1/N-cadherin expression and resistance metrics to compare culture conditions.
- Translational Research: Connects discovery to preclinical work by producing endothelial-stromal grafts on biomaterials for implantation studies.
- Enterprise Reuse: Allows repeated explant use from single donor tissue, establishing a sustainable cell source for long-term project continuity.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in endothelial phenotype maintenance, reducing mechanistic ambiguity in corneal regeneration models.
- Operational Value: Standardized explant isolation and subculture protocols enhance reproducibility and scalability across laboratories.
- Strategic Value: Enables risk-adjusted go/no-go decisions in corneal graft development by providing reliable preclinical efficacy and safety data.
- Portfolio Impact: Supports prioritization of biomaterials based on endothelial layer formation and functional integrity in engineered tissues.
Implementation Considerations
- Requires expertise in corneal tissue dissection and sterile explant handling under microscopy.
- Dependent on sterile micro Boyden chamber assembly and biomaterial disk preparation for dual-surface culture.
- Necessitates standardized dispase II concentration and incubation times for gentle, selective cell lifting.
- Requires adaptation of culture medium and attachment factor for species-specific endothelial cell adhesion (human vs. sheep).
- Limited by donor tissue availability and explant viability, necessitating timely processing post-enucleation.
Biopharma FAQs
Why does preventing epithelial-to-mesenchymal transition matter for corneal endothelial target validation?
Preventing EMT preserves the functional phenotype of corneal endothelial cells, ensuring that target validation assays reflect true barrier and pump activity rather than fibroblast-like dedifferentiation. This maintains assay relevance for screening compounds aimed at supporting corneal transparency and endothelial stability in regenerative medicine applications.
How does isolating corneal endothelium as explants support discovery pipeline efficiency?
Explant isolation enables direct culture of endogenous corneal endothelial cells without enzymatic dissociation, preserving cell-to-cell contact and reducing stress-induced phenotypic drift. This approach supports consistent, reproducible cell sourcing from donor tissue, improving reliability in early-stage target engagement and pathway modulation studies.
What quantitative measurements enable assessment of corneal endothelial layer integrity on biomaterials?
Electrical resistance measurements assess tight junction functionality and monolayer integrity, providing a quantitative, real-time readout of endothelial barrier properties on biomaterial membranes. Complementary immunofluorescence for ZO-1 and N-cadherin confirms junctional protein localization, supporting multimodal validation of culture quality.
Why are replication requirements critical for cross-functional collaboration in corneal tissue engineering?
Replication ensures that observed endothelial layer formation and phenotype stability are consistent across experiments, enabling reliable data sharing between discovery, preclinical, and translational teams. Standardized explant culture and subculture protocols reduce variability, supporting aligned decision-making in biomaterial selection and graft design.
What statistical analysis capabilities are required before implementing this corneal endothelial culture method?
Implementation requires capability to quantify and compare junctional protein expression (e.g., ZO-1, N-cadherin) and electrical resistance across culture conditions using appropriate statistical tests (e.g., t-tests, ANOVA) to determine significant differences. These analyses support objective evaluation of culture efficacy and biomaterial compatibility in preclinical development workflows.
